Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 04 May 2020 for Urovant Sciences Ltd.. Read the official filing
Filing timeline
BuySaleChristine Ocampo
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -6.9%Entry US$110.34 · Close at T+365 US$102.78
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Christine Ocampo: trading record in brief
Christine Ocampo has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Urovant Sciences Ltd. and Eledon Pharmaceuticals, Inc. We count 3 filings; the first trade dates from 10 May 2017 and the latest from 1 May 2020.
On the market, this insider has only ever bought: 1 purchase, €92k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 2 share grants.
The latest filing, published on 4 May 2020, reports a share grant in Urovant Sciences Ltd. The last insider purchase was made public on 11 May 2017, 3,450 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Christine Ocampo
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
44,346 shares0Common SharesSEC:0001209191-20-026839:0
32,833 shares0Common SharesSEC:0000899243-20-000882:0
10,010 shares@ US$9.99100.0% of flowCommon StockSEC:0000899243-17-012930:0
Canonical exit: 8 Aug 2017 (T+90)
3 of 3 declarations
